Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingNot applicable2026-09-11NCT01617161

13 results · Page 1 of 1

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Hospital of the University of PennsylvaniaPhiladelphiaUnited States142
Mass General/North Shore Cancer CenterDanversUnited States12
Massachusetts General HospitalBostonUnited States1015
Mayo ClinicRochesterUnited States664
Northwestern Medicine Chicago Proton CenterChicagoUnited States1
Princeton ProCure Proton Therapy CenterSomersetUnited States1
Provision Proton Therapy CenterKnoxvilleUnited States1
Rutgers Cancer Institute of New JerseyNew BrunswickUnited States223
University Hospital of ClevelandClevelandUnited States6
University of Florida Health Proton Therapy InstituteJacksonvilleUnited States5
University of Maryland Medical CenterCollege ParkUnited States1
University of Washington Medical CenterSeattleUnited States104
Washington UniversitySt LouisUnited States182